VIRsiRNAdb: a curated database of experimentally validated viral siRNA/shRNA
暂无分享,去创建一个
[1] Anitha Rao,et al. RNA-Based Gene Therapy for HIV with Lentiviral Vector–Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma , 2010, Science Translational Medicine.
[2] Kazuhiko Hayashi,et al. siRNA‐resistance in treated HCV replicon cells is correlated with the development of specific HCV mutations , 2006, Journal of viral hepatitis.
[3] Szymon M. Kielbasa,et al. HuSiDa—the human siRNA database: an open-access database for published functional siRNA sequences and technical details of efficient transfer into recipient cells , 2004, Nucleic Acids Res..
[4] Arndt Borkhardt,et al. RNA interference: new mechanisms for targeted treatment? , 2003, Reviews in clinical and experimental hematology.
[5] S. Abdolhamid Angaji,et al. Application of RNA interference in treating human diseases , 2010, Journal of Genetics.
[6] Ram I Mahato,et al. siRNA pool targeting different sites of human hepatitis B surface antigen efficiently inhibits HBV infection. , 2008, Journal of drug targeting.
[7] Xin Zheng,et al. BIOINFORMATICSAPPLICATIONS NOTE doi:10.1093/bioinformatics/btl026 Databases and ontologies , 2005 .
[8] A. Fire,et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.
[9] Manoj Kumar,et al. HIVsirDB: A Database of HIV Inhibiting siRNAs , 2011, PloS one.
[10] E. Holmes,et al. Rates of evolutionary change in viruses: patterns and determinants , 2008, Nature Reviews Genetics.
[11] David V. Schaffer,et al. Antiviral RNAi: Translating Science Towards Therapeutic Success , 2011, Pharmaceutical Research.
[12] P. Linsley,et al. Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application , 2010, Nature Reviews Drug Discovery.
[13] Yuki Naito,et al. Optimal design and validation of antiviral siRNA for targeting HIV-1 , 2007, Retrovirology.
[14] Rob Lambkin-Williams,et al. A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus , 2010, Proceedings of the National Academy of Sciences.
[15] Ben Berkhout,et al. Nucleic Acids-Based Therapeutics in the Battle Against Pathogenic Viruses , 2009, Handbook of experimental pharmacology.
[16] Ben Berkhout,et al. Human Immunodeficiency Virus Type 1 Escapes from RNA Interference-Mediated Inhibition , 2004, Journal of Virology.
[17] G Narahari Sastry,et al. DSTHO: database of siRNAs targeted at human oncogenes: a statistical analysis. , 2006, International journal of biological macromolecules.
[18] Michael Zuker,et al. Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..
[19] D. Schaffer,et al. Antiviral RNAi therapy: emerging approaches for hitting a moving target , 2005, Gene Therapy.
[20] Erik L. L. Sonnhammer,et al. siRNA specificity searching incorporating mismatch tolerance data . – Supplementary Data , 2008 .
[21] W. Filipowicz,et al. RNAi: The Nuts and Bolts of the RISC Machine , 2005, Cell.
[22] Erik L. L. Sonnhammer,et al. siRNAdb: a database of siRNA sequences , 2004, Nucleic Acids Res..
[23] Anastasia Khvorova,et al. Addendum: 3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets , 2006 .
[24] Anastasia Khvorova,et al. 3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets , 2006, Nature Methods.
[25] Ben Berkhout,et al. Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition , 2008, Molecular Therapy.
[26] M. Kimmel,et al. Conflict of interest statement. None declared. , 2010 .
[27] John Maraganore,et al. A status report on RNAi therapeutics , 2010, Silence.
[28] P. Arbuthnot,et al. Harnessing RNA interference for the treatment of viral infections. , 2010, Drug news & perspectives.
[29] D. Haussecker,et al. The business of RNAi therapeutics. , 2008, Human gene therapy.
[30] I. Longden,et al. EMBOSS: the European Molecular Biology Open Software Suite. , 2000, Trends in genetics : TIG.
[31] Eugene W. Myers,et al. Optimal alignments in linear space , 1988, Comput. Appl. Biosci..
[32] R. Tripp,et al. Therapeutic applications of RNAi for silencing virus replication. , 2009, Methods in molecular biology.
[33] B. Berkhout,et al. RNA interference against viruses: strike and counterstrike , 2007, Nature Biotechnology.
[34] Mario Stevenson,et al. Therapeutic potential of RNA interference. , 2004, The New England journal of medicine.
[35] Michael T. McManus,et al. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[36] Heuiran Lee,et al. Antiviral potency of a siRNA targeting a conserved region of coxsackievirus A24. , 2008, Biochemical and biophysical research communications.
[37] Catherine H. Wu,et al. Inhibition of HBV replication by siRNA in a stable HBV‐producing cell line , 2003, Hepatology.
[38] Erik L. L. Sonnhammer,et al. siRNA specificity searching incorporating mismatch tolerance data , 2008, Bioinform..
[39] Christopher D. Richardson,et al. Hepatitis C Virus Replicons Escape RNA Interference Induced by a Short Interfering RNA Directed against the NS5b Coding Region , 2005, Journal of Virology.
[40] K. Ui-Tei,et al. Thermodynamic stability and Watson–Crick base pairing in the seed duplex are major determinants of the efficiency of the siRNA-based off-target effect , 2008, Nucleic acids research.
[41] B. Li,et al. Expression profiling reveals off-target gene regulation by RNAi , 2003, Nature Biotechnology.
[42] Beverly L. Davidson,et al. Current prospects for RNA interference-based therapies , 2011, Nature Reviews Genetics.
[43] Anastasia Khvorova,et al. Experimental validation of the importance of seed complement frequency to siRNA specificity. , 2008, RNA.
[44] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[45] S. Kauppinen,et al. Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection , 2010, Science.
[46] Yuki Naito,et al. siVirus: web-based antiviral siRNA design software for highly divergent viral sequences , 2006, Nucleic Acids Res..
[47] Jie Xiong,et al. Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs , 2005, Cell Research.
[48] M. López‐Fraga,et al. RNA Interference Technologies and Therapeutics , 2012, BioDrugs.